Ensign Peak Advisors »

Supernus Pharmaceuticals shares owned by Ensign Peak Advisors

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Ensign Peak Advisors from 13F filings

Historical chart of Ensign Peak Advisors investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Ensign Peak Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $849k 25k 34.11
2023-09-30 $721k 26k 27.57
2023-06-30 $786k 26k 30.06
2023-03-31 $947k 26k 36.23
2022-12-31 $933k 26k 35.67
2022-09-30 $655k 19k 33.86
2022-06-30 $559k 19k 28.89
2022-03-31 $625k 19k 32.31
2021-12-31 $564k 19k 29.15
2021-09-30 $1.3M 50k 26.67
2021-06-30 $1.5M 50k 30.79
2021-03-31 $1.3M 50k 26.18
2020-12-31 $1.3M 50k 25.16
2020-09-30 $1.1M 53k 20.84
2020-06-30 $1.2M 53k 23.76
2020-03-31 $944k 53k 17.99
2019-12-31 $1.2M 52k 23.73